Deprenyl induces the tyrosine hydroxylase enzyme in the rat dopaminergic nigrostriatal system
Identifieur interne : 001F61 ( Main/Exploration ); précédent : 001F60; suivant : 001F62Deprenyl induces the tyrosine hydroxylase enzyme in the rat dopaminergic nigrostriatal system
Auteurs : José A. Rodr Guez-G Mez [Espagne] ; José L. Venero [Espagne] ; Mar A L. Vizuete [Espagne] ; Josefina Cano [Espagne] ; Alberto Machado [Espagne]Source :
- Molecular Brain Research [ 0169-328X ] ; 1996.
Abstract
Chronic treatment of aged rats with deprenyl prevents age-induced protein oxidation in substantia nigra and protects tyrosine hydroxylase (TH) enzyme against inactivation [11]. With these precedents, we treated adult rats with deprenyl for 3 weeks in order to get further insight in the mechanism by which deprenyl exerts such actions. After completing the treatment, dopamine (DA) levels markedly increased in both striatum and substantia nigra while levels of the acid DA metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), decreased in the two brain areas, thus proving MAO-inhibiting properties of the treatment. We then studied the cellular expression of TH mRNA by in situ hybridization. Following treatment with deprenyl, levels of TH mRNA were significantly higher in individual dopaminergic nigral cell bodies than in those of control rats (+74%). Western blotting analysis of TH enzyme amount revealed a positive effect of the treatment in both the terminal field (+44%) and the cell body region (+31%). This correlation between TH mRNA and amount was also extended to TH enzyme activity in the two brain areas studied, which significantly increased in striatum (+57%) and substantia nigra (+35%) following deprenyl treatment. Taken together, our results clearly suggest a TH-inducing effect of deprenyl in the dopaminergic nigrostriatal system, which seems to be independent of its protective action against oxidative stress described previously. These results expand our knowledge about the beneficial effect of deprenyl in the therapy of Parkinson's disease.
Url:
DOI: 10.1016/S0169-328X(96)00270-7
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Deprenyl induces the tyrosine hydroxylase enzyme in the rat dopaminergic nigrostriatal system</title><author><name sortKey="Rodr Guez G Mez, Jose A" sort="Rodr Guez G Mez, Jose A" uniqKey="Rodr Guez G Mez J" first="José A" last="Rodr Guez-G Mez">José A. Rodr Guez-G Mez</name></author><author><name sortKey="Venero, Jose L" sort="Venero, Jose L" uniqKey="Venero J" first="José L" last="Venero">José L. Venero</name></author><author><name sortKey="Vizuete, Mar A L" sort="Vizuete, Mar A L" uniqKey="Vizuete M" first="Mar A L" last="Vizuete">Mar A L. Vizuete</name></author><author><name sortKey="Cano, Josefina" sort="Cano, Josefina" uniqKey="Cano J" first="Josefina" last="Cano">Josefina Cano</name></author><author><name sortKey="Machado, Alberto" sort="Machado, Alberto" uniqKey="Machado A" first="Alberto" last="Machado">Alberto Machado</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:8A4B2053CA6B91E07F0491803412D001866F4B96</idno><date when="1997" year="1997">1997</date><idno type="doi">10.1016/S0169-328X(96)00270-7</idno><idno type="url">https://api.istex.fr/document/8A4B2053CA6B91E07F0491803412D001866F4B96/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002F02</idno><idno type="wicri:Area/Main/Curation">002B15</idno><idno type="wicri:Area/Main/Exploration">001F61</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Deprenyl induces the tyrosine hydroxylase enzyme in the rat dopaminergic nigrostriatal system</title><author><name sortKey="Rodr Guez G Mez, Jose A" sort="Rodr Guez G Mez, Jose A" uniqKey="Rodr Guez G Mez J" first="José A" last="Rodr Guez-G Mez">José A. Rodr Guez-G Mez</name><affiliation wicri:level="2"><country xml:lang="fr">Espagne</country><wicri:regionArea>Departamento de Bioquı́mica, Bromatologı́a y Toxicologı́a, Facultad de Farmacia, Universidad de Sevilla, C. Prof. Garcı́a González s/n, 41012 Seville</wicri:regionArea><placeName><region nuts="2" type="communauté">Andalousie</region></placeName></affiliation></author><author><name sortKey="Venero, Jose L" sort="Venero, Jose L" uniqKey="Venero J" first="José L" last="Venero">José L. Venero</name><affiliation wicri:level="2"><country xml:lang="fr">Espagne</country><wicri:regionArea>Departamento de Bioquı́mica, Bromatologı́a y Toxicologı́a, Facultad de Farmacia, Universidad de Sevilla, C. Prof. Garcı́a González s/n, 41012 Seville</wicri:regionArea><placeName><region nuts="2" type="communauté">Andalousie</region></placeName></affiliation></author><author><name sortKey="Vizuete, Mar A L" sort="Vizuete, Mar A L" uniqKey="Vizuete M" first="Mar A L" last="Vizuete">Mar A L. Vizuete</name><affiliation wicri:level="2"><country xml:lang="fr">Espagne</country><wicri:regionArea>Departamento de Bioquı́mica, Bromatologı́a y Toxicologı́a, Facultad de Farmacia, Universidad de Sevilla, C. Prof. Garcı́a González s/n, 41012 Seville</wicri:regionArea><placeName><region nuts="2" type="communauté">Andalousie</region></placeName></affiliation></author><author><name sortKey="Cano, Josefina" sort="Cano, Josefina" uniqKey="Cano J" first="Josefina" last="Cano">Josefina Cano</name><affiliation wicri:level="2"><country xml:lang="fr">Espagne</country><wicri:regionArea>Departamento de Bioquı́mica, Bromatologı́a y Toxicologı́a, Facultad de Farmacia, Universidad de Sevilla, C. Prof. Garcı́a González s/n, 41012 Seville</wicri:regionArea><placeName><region nuts="2" type="communauté">Andalousie</region></placeName></affiliation></author><author><name sortKey="Machado, Alberto" sort="Machado, Alberto" uniqKey="Machado A" first="Alberto" last="Machado">Alberto Machado</name><affiliation wicri:level="2"><country xml:lang="fr">Espagne</country><wicri:regionArea>Departamento de Bioquı́mica, Bromatologı́a y Toxicologı́a, Facultad de Farmacia, Universidad de Sevilla, C. Prof. Garcı́a González s/n, 41012 Seville</wicri:regionArea><placeName><region nuts="2" type="communauté">Andalousie</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Molecular Brain Research</title><title level="j" type="abbrev">BRESM</title><idno type="ISSN">0169-328X</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1996">1996</date><biblScope unit="volume">46</biblScope><biblScope unit="issue">1–2</biblScope><biblScope unit="page" from="31">31</biblScope><biblScope unit="page" to="38">38</biblScope></imprint><idno type="ISSN">0169-328X</idno></series><idno type="istex">8A4B2053CA6B91E07F0491803412D001866F4B96</idno><idno type="DOI">10.1016/S0169-328X(96)00270-7</idno><idno type="PII">S0169-328X(96)00270-7</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0169-328X</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Chronic treatment of aged rats with deprenyl prevents age-induced protein oxidation in substantia nigra and protects tyrosine hydroxylase (TH) enzyme against inactivation [11]. With these precedents, we treated adult rats with deprenyl for 3 weeks in order to get further insight in the mechanism by which deprenyl exerts such actions. After completing the treatment, dopamine (DA) levels markedly increased in both striatum and substantia nigra while levels of the acid DA metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), decreased in the two brain areas, thus proving MAO-inhibiting properties of the treatment. We then studied the cellular expression of TH mRNA by in situ hybridization. Following treatment with deprenyl, levels of TH mRNA were significantly higher in individual dopaminergic nigral cell bodies than in those of control rats (+74%). Western blotting analysis of TH enzyme amount revealed a positive effect of the treatment in both the terminal field (+44%) and the cell body region (+31%). This correlation between TH mRNA and amount was also extended to TH enzyme activity in the two brain areas studied, which significantly increased in striatum (+57%) and substantia nigra (+35%) following deprenyl treatment. Taken together, our results clearly suggest a TH-inducing effect of deprenyl in the dopaminergic nigrostriatal system, which seems to be independent of its protective action against oxidative stress described previously. These results expand our knowledge about the beneficial effect of deprenyl in the therapy of Parkinson's disease.</div></front></TEI><affiliations><list><country><li>Espagne</li></country><region><li>Andalousie</li></region></list><tree><country name="Espagne"><region name="Andalousie"><name sortKey="Rodr Guez G Mez, Jose A" sort="Rodr Guez G Mez, Jose A" uniqKey="Rodr Guez G Mez J" first="José A" last="Rodr Guez-G Mez">José A. Rodr Guez-G Mez</name></region><name sortKey="Cano, Josefina" sort="Cano, Josefina" uniqKey="Cano J" first="Josefina" last="Cano">Josefina Cano</name><name sortKey="Machado, Alberto" sort="Machado, Alberto" uniqKey="Machado A" first="Alberto" last="Machado">Alberto Machado</name><name sortKey="Venero, Jose L" sort="Venero, Jose L" uniqKey="Venero J" first="José L" last="Venero">José L. Venero</name><name sortKey="Vizuete, Mar A L" sort="Vizuete, Mar A L" uniqKey="Vizuete M" first="Mar A L" last="Vizuete">Mar A L. Vizuete</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F61 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001F61 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:8A4B2053CA6B91E07F0491803412D001866F4B96
|texte= Deprenyl induces the tyrosine hydroxylase enzyme in the rat dopaminergic nigrostriatal system
}}
| This area was generated with Dilib version V0.6.23. |  |